Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
20.88
-0.26 (-1.23%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Tandem Diabetes Care Revenue
In the year 2025, Tandem Diabetes Care had annual revenue of $1.01B with 7.93% growth. Tandem Diabetes Care had revenue of $290.38M in the quarter ending December 31, 2025, with 2.74% growth.
Revenue (ttm)
$1.01B
Revenue Growth
+7.93%
P/S Ratio
1.41
Revenue / Employee
$405,894
Employees
2,500
Market Cap
1.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.01B | 74.53M | 7.93% |
| Dec 31, 2024 | 940.20M | 192.49M | 25.74% |
| Dec 31, 2023 | 747.72M | -53.50M | -6.68% |
| Dec 31, 2022 | 801.22M | 98.42M | 14.00% |
| Dec 31, 2021 | 702.80M | 203.97M | 40.89% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| QuidelOrtho | 2.73B |
| Enovis | 2.25B |
| CONMED | 1.37B |
| Inspire Medical Systems | 911.98M |
| NovoCure | 655.35M |
| UFP Technologies | 602.80M |
| Artivion | 441.33M |
TNDM News
- 5 days ago - Tandem Mobi Now Compatible with Android Smartphones - Business Wire
- 11 days ago - Tandem Diabetes Care, Inc. (TNDM) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript - Seeking Alpha
- 13 days ago - Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032 - Business Wire
- 14 days ago - Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes - Business Wire
- 14 days ago - Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition - Seeking Alpha
- 17 days ago - Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook - Benzinga
- 17 days ago - Tandem Diabetes Care Analysts Boost Their Forecasts After Upbeat Q4 Results - Benzinga
- 18 days ago - Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript - Seeking Alpha